These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
96 related articles for article (PubMed ID: 1161314)
61. An immunologic look at the TNM classification: therapeutic implications and strategies. Israel L Cancer Treat Rep; 1978 Aug; 62(8):1177-82. PubMed ID: 688254 [No Abstract] [Full Text] [Related]
63. [STUDY OF POSSIBILITIES OF PASSIVE IMMUNIZATION AGAINST THE EHRLICH SOLID TUMOR]. MAZUREK C; DUPLAN JF Bull Assoc Fr Etud Cancer; 1963; 50():545-52. PubMed ID: 14135192 [No Abstract] [Full Text] [Related]
64. CHANGES IN NON-LYMPHOID RETICULOENDOTHELIAL CELL DERIVATIVES OF MICE DURING IMMUNIZATION AND CHALLENGE WITH THE EHRLICH TUMOR. BAILLIF RN J Reticuloendothel Soc; 1964 Jul; 1():185-207. PubMed ID: 14192582 [No Abstract] [Full Text] [Related]
65. Immunological competence of heat-treated extracts of tumor or lymph nodes. Castillo J; Goldsmith HS Arch Surg; 1973 Mar; 106(3):322-4. PubMed ID: 4574230 [No Abstract] [Full Text] [Related]
66. Lymph-node metastases after intratibial transplantation of tumors. Franchi G; Innocenti IR; Rosso R; Garattini S Int J Cancer; 1968 Nov; 3(6):765-70. PubMed ID: 5731981 [No Abstract] [Full Text] [Related]
67. Discordance between larger tumor size and less lymph node metastases in metaplastic breast carcinomas: Any biological rationale behind this fact? Altundag K J BUON; 2020; 25(2):1267. PubMed ID: 32521937 [No Abstract] [Full Text] [Related]
68. The organ status of lymph nodes in cancer metastasis. Onuigbo WI Oncology; 1973; 28(3):227-31. PubMed ID: 4767108 [No Abstract] [Full Text] [Related]
69. The spread of cancer in the organism. Facts and problems. Sträuli P Naturwissenschaften; 1977 Aug; 64(8):403-9. PubMed ID: 917116 [TBL] [Abstract][Full Text] [Related]
70. Biological considerations in the treatment of cancer. Crile G Cleve Clin Q; 1972; 39(4):145-52. PubMed ID: 4660196 [No Abstract] [Full Text] [Related]
71. [Generalized primary sarcoma of conjunctiva including the lymphatic apparatus]. VANCEA P; LAZARESCU D; CERNE G; VAIGHEL V Arch Ophtalmol Rev Gen Ophtalmol; 1959; 19(1):5-12. PubMed ID: 13638058 [No Abstract] [Full Text] [Related]
74. Macrophage migration inhibition-activity after implantation of methylcholanthrene-induced sarcoma, Ehrlich ascites cancer or mouse ascites hepatoma-134 cancer cells in mice. Yumura M Acta Med Okayama; 1976 Feb; 30(1):37-48. PubMed ID: 184687 [TBL] [Abstract][Full Text] [Related]
75. Studies on the tumor-host relationship. II. Serum resistant factor(s) produced by tumor transplantation. Tanino T Jpn J Exp Med; 1968 Oct; 38(5):383-92. PubMed ID: 5305973 [No Abstract] [Full Text] [Related]
76. Studies on lymphatic metastasis. I. Primary immunoregulatory role of regional lymph nodes in the establishment of lymphatic metastases. Yoshida K; Tachibana T J Natl Cancer Inst; 1985 Dec; 75(6):1049-58. PubMed ID: 2866267 [TBL] [Abstract][Full Text] [Related]
77. Recurrent and metastatic malignant disease: immunological considerations. Carter RL Proc R Soc Med; 1974 Sep; 67(9):852-4. PubMed ID: 4610589 [No Abstract] [Full Text] [Related]
78. [Recent advances in the study of metastases]. Carter RL Recenti Prog Med; 1973 May; 54(5):404-21. PubMed ID: 4581375 [No Abstract] [Full Text] [Related]